Kidney cancer trials in Australia
30 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)
- Where
- Macquarie University, Melbourne, Murdoch, Woolloongabba
- Age
- 18 years and over
- People
- 758 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07489495 · EU 2024-516993-31-00 - Phase 1Taking peopleA Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
- Where
- Camperdown, Melbourne, Sydney
- Age
- 18 years and over
- People
- 362 worldwide
- Run by
- Arcus Biosciences, Inc.
See details and how to joinNCT05536141 · EU 2024-519142-70-00 - Phase 3Taking peopleStudy of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
- Where
- Box Hill, Chermside, Elizabeth Vale, Frankston, Frenchs Forest, Heidelberg, Hobart, Kurralta Park, Macquarie Park, New South Wales, South Brisbane, St Albans, Subiaco, Westmead
- Age
- 18 years and over
- People
- 720 worldwide
- Run by
- Arcus Biosciences, Inc.
See details and how to joinNCT07011719 · EU 2024-515023-11-00 - Phase 2Taking peoplePsilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder
- Where
- Abbotsford, Leederville, Melbourne, Northcote
- Age
- 18 years to 80 years
- People
- 87
- Run by
- Psyence Australia Pty Ltd
See details and how to joinNCT07072728 - Phase 1Taking peopleA Study of MGC026 in Participants With Advanced Solid Tumors
- Where
- Auchenflower, Heidelberg, Kurralta Park
- Age
- 18 years and over
- People
- 394 worldwide
- Run by
- MacroGenics
See details and how to joinNCT06242470 - Phase 2Not yet taking people in AustraliaNeoadjuvant Belzutifan Plus Pembrolizumab in High-Risk, Locally Advanced Clear Cell Renal Cell Carcinoma
- Where
- Melbourne
- Age
- 18 years and over
- People
- 30
- Run by
- Peter MacCallum Cancer Centre, Australia
See details and how to joinNCT07840001 - Phase 2Taking peopleTesting the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
- Where
- Melbourne
- Age
- 18 years and over
- People
- 240 worldwide
- Run by
- NRG Oncology
See details and how to joinNCT05327686 - Phase 1/2Taking peopleA Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
- Where
- Brisbane, Heidelberg, Herston, Malvern, North Ryde, St Leonards
- Age
- 18 years and over
- People
- 474 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07293351 · EU 2026-527163-15-00 - Early phase 1Taking peopleImaging Study in Metastatic Clear Cell RCC.
- Where
- Nedlands, Perth, Saint Leonards
- Age
- 18 years and over
- People
- 10 worldwide
- Run by
- RayzeBio, Inc.
See details and how to joinNCT07671417 - Phase 1Taking peopleA Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
- Where
- Adelaide, Melbourne, Sydney, Woolloongabba
- Age
- 18 years and over
- People
- 280 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT07195916 · EU 2025-523130-11-00 - Phase 1/2Taking peopleA Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
- Where
- East Melbourne
- Age
- 18 years and over
- People
- 120 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07115043 - Phase 1/2Taking peopleSymbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
- Where
- Auchenflower, Clayton
- Age
- 18 years and over
- People
- 224 worldwide
- Run by
- Pfizer
See details and how to joinNCT07227415 · EU 2025-523524-53-00 - Phase 1Taking peopleStudy of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Where
- Albury, Birtinya, Brisbane, Saint Leonards, Sydney
- Age
- 18 years and over
- People
- 1,394 worldwide
- Run by
- Exelixis
See details and how to joinNCT05176483 · EU 2023-510061-10-00 - Phase 1/2Taking peopleStudy of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
- Where
- Bedford Park, Clayton, Frankston, Heidelberg, Melbourne, Miranda, Saint Albans
- Age
- 18 years and over
- People
- 159 worldwide
- Run by
- Aulos Bioscience, Inc.
See details and how to joinNCT05267626 - Phase 1/2Taking peopleSL-28 for Advanced Solid Tumours
- Where
- Adelaide, Gold Coast, Sydney
- Age
- 18 years and over
- People
- 60
- Run by
- Second Life Therapeutics
See details and how to joinNCT07341737 - Phase 1/2Taking peopleSafety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors
- Where
- Adelaide, Clayton, Randwick, Southport
- Age
- 18 years and over
- People
- 248 worldwide
- Run by
- BioNTech SE
See details and how to joinNCT06750185 - No phaseTaking peopleProject: Every Child for Younger Patients With Cancer
- Where
- Clayton, Hunter Regional Mail Centre, North Adelaide, Parkville, Perth, Randwick, Saint Hobart, South Brisbane, Westmead
- Age
- Up to 25 years
- People
- 75,000 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT02402244 - Phase 2Taking peopleA Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
- Where
- Clayton, Hunter Regional Mail Centre, North Adelaide, Parkville, Perth, Randwick, South Brisbane, Westmead
- Age
- Up to 30 years
- People
- 256 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT04322318 - Phase 1Taking peopleA First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid Tumors
- Where
- Southport, Waratah
- Age
- 18 years to 75 years
- People
- 299 worldwide
- Run by
- Huahui Health
See details and how to joinNCT07623369 - Phase 1/2Taking peopleA Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
- Where
- Blacktown, Brisbane, Liverpool, Malvern, Melbourne, Nedlands
- Age
- 18 years and over
- People
- 1,109 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT04895709 - Phase 1/2Taking peopleA Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors
- Where
- Melbourne, Sydney
- Age
- 18 years and over
- People
- 270 worldwide
- Run by
- Lumara Bio Oncologics GmbH
See details and how to joinNCT05706129 · EU 2023-504254-35-00 - Phase 1Taking peopleIDOV-Immune for Advanced Solid Tumors
- Where
- Melbourne, Westmead
- Age
- 18 years and over
- People
- 78 worldwide
- Run by
- ViroMissile, Inc.
See details and how to joinNCT06910657 - Phase 3Taking peopleA Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)
- Where
- Sydney
- Age
- 18 years and over
- People
- 904 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07227402 · EU 2024-517136-21-00 - Phase 1Taking peopleA Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors
- Where
- Brisbane
- Age
- 18 years and over
- People
- 437 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06764771 - No phaseTaking peopleLEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology
- Where
- Melbourne, Saint Leonards, Woolloongabba
- Age
- 18 years and over
- People
- 300
- Run by
- University of Sydney
See details and how to joinNCT05184790